Abeona Therapeutics Inc vs Innodata Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Innodata Inc trades at $63.56 (market cap $2.05B). The key difference: Innodata Inc is far larger — about 4.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | INOD | |
|---|---|---|
Market Cap | $421.19M | $2.05B |
Sector | Health | Technology |
52-Week High | $7.45 | $121.50 |
52-Week Low | $4.17 | $34.45 |
Enterprise Value | $276.10M | $1.80B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →